Research sheds new light on the link between gut bacteria and anxiety

August 24, 2017, BioMed Central
Credit: CC0 Public Domain

Research published in the open access journal Microbiome sheds new light on how gut bacteria may influence anxiety-like behaviors. Investigating the link between gut bacteria and biological molecules called microRNAs (miRNAs) in the brain; researchers at the APC Microbiome Institute at University College Cork, which is funded by Science Foundation Ireland, found that a significant number of miRNAs were changed in the brains of microbe-free mice. These mice are reared in a germ-free bubble and typically display abnormal anxiety, deficits in sociability and cognition, and increased depressive-like behaviors.

Dr Gerard Clarke, the corresponding author said: "Gut microbes seem to influence miRNAs in the amygdala and the . This is important because these miRNAs may affect physiological processes that are fundamental to the functioning of the central nervous system and in regions, such as the amygdala and prefrontal cortex, which are heavily implicated in anxiety and depression."

miRNAs are short sequences of nucleotides (the building blocks of DNA and RNA), which can act to control how genes are expressed. miRNA dysregulation or dysfunction is believed to be an underlying factor contributing to stress-related psychiatric disorders, neurodegenerative diseases and neurodevelopmental abnormalities. miRNA changes in the brain have been implicated in anxiety-like behaviors.

Dr Clarke said: "It may be possible to modulate miRNAs in the brain for the treatment of but research in this area has faced several challenges, for example, finding safe and biologically stable compounds that are able to cross the blood-brain barrier and then act at the desired location in the brain. Our study suggests that some of the hurdles that stand in the way of exploiting the therapeutic potential of miRNAs could be cleared by instead targeting the gut ."

The researchers found that levels of 103 miRNAs were different in the amygdala and 31 in the prefrontal cortex of reared without gut bacteria (GF mice) compared to conventional mice. Adding back the gut microbiome later in life normalized some of the changes to miRNAs in the brain.

The findings suggest that a healthy microbiome is necessary for appropriate regulation of miRNAs in these brain regions. Previous research demonstrated that manipulation of the gut microbiome affects anxiety-like behaviors but this is the first time that the has been linked to miRNAs in both the amygdala and prefrontal cortex, according to the authors.

The researchers used next-generation-sequencing (NGS) to find out which miRNAs were present in the amygdala and the prefrontal cortex of groups of 10-12 control mice with a normal gut microbiota, GF mice and ex-GF mice—which had been colonized with bacteria by housing them with the control mice—and adult rats whose normal microbiota had been depleted with antibiotics.

They found that depleting the microbiota of adult rats with antibiotics impacted some miRNAs in the brain in a similar way to the GF mice. This suggests that even if a healthy microbiota is present in early life, subsequent changes in adulthood can impact miRNAs in the brain relevant to anxiety-like behaviors, according to the authors.

The authors note that the exact mechanism by which the gut microbiota is able to influence the miRNAs in the brain remains unclear. Even though the study shows that effects of the microbiota on miRNAs are present in more than one species (mice and rats), further research into the possible connection between , miRNAs and anxiety-like behaviors is needed before the findings can be translated to a clinical setting.

Dr Clarke said: "This is early stage research but the possibility of achieving the desired impact on miRNAs in specific by targeting the gut microbiota—for example by using psychobiotics—is an appealing prospect."

Explore further: MicroRNA biomarker signature identified for allergic asthma

More information: Alan E. Hoban et al, Microbial regulation of microRNA expression in the amygdala and prefrontal cortex, Microbiome (2017). DOI: 10.1186/s40168-017-0321-3

Related Stories

MicroRNA biomarker signature identified for allergic asthma

June 1, 2017
(HealthDay)—Certain plasma microRNAs (miRNAs) are differentially regulated in allergic asthma and correlate with clinical characteristics, according to an experimental study published online May 17 in Allergy.

Mechanisms, therapeutic targets of microRNA-associated chemoresistance in epithelial ovarian cancer

June 16, 2016
Epithelial ovarian cancer (EOC) is the most lethal disease among gynecologic malignancies. Patients with an advanced disease often relapse due to the development of chemoresistance. Chemotherapy failure is a consequence of ...

Brain cells found to control aging

July 26, 2017
Scientists at Albert Einstein College of Medicine have found that stem cells in the brain's hypothalamus govern how fast aging occurs in the body. The finding, made in mice, could lead to new strategies for warding off age-related ...

MicroRNAs show promise for revealing radiation exposure and likelihood of survival

March 2, 2017
Ionizing radiation incidents—nuclear war, nuclear accidents or terrorist dirty bombs, for example—can cause mass fatalities. Since resources for medical countermeasures are limited, it's critically important to swiftly ...

A microRNA plays role in major depression

September 9, 2016
A tiny RNA appears to play a role in producing major depression, the mental disorder that affects as many as 250 million people a year worldwide.

Recommended for you

Human 'chimeric' cells restore crucial protein in Duchenne muscular dystrophy

March 16, 2018
Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne muscular dystrophy —a rare but fatal form of muscular dystrophy—were able to significantly improve muscle function when implanted ...

Team develops 3-D tissue model of a developing human heart

March 16, 2018
The heart is the first organ to develop in the womb and the first cause of concern for many parents.

Genetic variant discovery to help asthma sufferers

March 16, 2018
Research from the University of Liverpool, published today in Lancet Respiratory Medicine, identifies a genetic variant that could improve the safety and effectiveness of corticosteroids, drugs that are used to treat a range ...

Researchers say use of artificial intelligence in medicine raises ethical questions

March 15, 2018
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.

Study identifies potential drug for treatment of debilitating inherited neurological disease

March 15, 2018
St. Jude Children's Research Hospital scientists have demonstrated in mouse studies that the neurological disease spinal bulbar muscular atrophy (SBMA) can be successfully treated with drugs. The finding paves the way for ...

Clearing clumps of protein in aging neural stem cells boosts their activity

March 15, 2018
Young, resting neural stem cells in the brains of mice store large clumps of proteins in specialized cellular trash compartments known as lysosomes, researchers at the Stanford University School of Medicine have found.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Aug 25, 2017
Does this not suggest fecal transplant from a donor w/o any history of anxiety??

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.